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WHILE investigating the effects of
C. parvum administration on tumour
growth in mice, we observed a number of
serological responses. For example, anti-
bodies which react with C. parvum and
with the cells of a chemically induced
fibrosarcoma were elicited, and there was
also a marked increase in the level of
certain immunoglobulins (Woodruff,
McBride and Dunbar, 1974; James et al.,
1976). These effects (as well as the
antitumour properties) were observed in
both intact mice and mice made T-cell-
deficient by adult thymectomy, whole-
body irradiation and rescue with isogeneic
bone marrow (James et al., 1976; Wood-
ruff, Dunbar and Ghaffar, 1973). In view
of the suggestion that the antibody
responses in B mice might be due either to
the expansion of a residual T-cell popula-
tion (Woodruffet al., 1974) or to some form
of T-cell bypass mechanism (Howard,
Scott and Christie, 1973), we felt it was
important to examine the serological
effects of C. parPum in nude mice. We
therefore undertook the following investi-
gations.
Athymic (nu nu) BALB/c male mice,
and litter-mates heterozygous for the nu
gene (nu +-) aged between 8 and 12 weeks
were injected i.v. or i.p. with 0 7 mg (dry
weight) C. parvum (strain CN6134) and
bled out 21 days later. Untreated control
nu nu and nu+BALB/c mice were bled at
the same time. The serum was separated
and stored at 20°C. The mice were
supplied by G. L. Bomholtgaard, Dyrlaege,
8680 Ry, Denmark. The cages were
placed in a tissue-culture cabinet and the
mice were fed Oxoid pellets sterilized by y
radiation. The drinking water was not
sterilized.
Serum from individual mice was as-
sayed, as described previously. The anti-
C. parrum antibody was determined by a
modification (Woodruff et al., 1974) of the
latex agglutination test of Florman and
Scoma (1960), and immunoglobulin class
and subclass levels by the single radial
immunodiffusion method of Mancini,
Carbonara and Heremans (1965), the
standard serum being calibrated against
purified proteins (supplied by Litton
Bionetics Inc., Kensington, Maryland,
USA). Antibodies cross-reacting with a
methylcholanthrene-induced CBA-strain
fibrosarcoma were assayed by a modifica-
tion (James et al., 1976) of the indirect
antiglobulin assay of Nossal et al. (1972).
The results are summarized in Tables I
and II. It is clear that administration of
C. parvum (i.v. or i.p.) to homozygous
nude mice resulted in significant produc-
tion of antibodies to this organism,
though the response was less marked than
in heterozygous litter-mate controls.
The i.v. injection of C. parvum into homo-
zygous nudes also resulted in a significant
increase in serum IgM and IgG2a levels,
and in splenomegaly similar to that
produced in heterozygotes. I.p. injection
of C. parvum had a less marked effect on
these parameters. Increases in antitumour
antibody levels were also noted in allC. PARVUM TREATMENT OF NUDE MICE
TABLE I.-Antibodies to C. parvum and Allogeneic Tumour, and Changes in Spleen
Weight, After C. parvum Administration to Homozygous (nu nu) and Heterozygous
(nu+) Nude Mice
Treatmentb
No treatment
0-7 mg C. parvum i.v.
,, 9 00-7 mg C. parvum i.p.
D nu nu No treatment
,,9 0-7 mg C. parvum i.v.
,9 -0 7 mg C. parvum i.p.
Antibodies to
C. parvum
log2d
3-6
(3-1-3-6)
10-4
(8 -9-10 -9)**
10-9
(9 -9-11 -9)**
2-6
(2 -6-3-6)
5-6
(3-6-6- 1)**
4-6
(4 6-5 6)**
Antibodies to
allogeneic tumourC
ct/min4
2026
(1546-2752)
2509
(1673-3297)
3409
(2969-4096)**
2084
(1176-3480)
3298
(3062-4252)
3061
(1286-4196)
a Each group contained 7 to 8 male mice, the nu + and nu nu mice being litter-mates.
b 21 days before the antibody assays and spleen weight determinations.
c The target cell in this assay was a cultured methylcholanthrene-induced fibrosarcoma from CBA mice.
d The antibody measurements and spleen weights are expressed as median values, together with values
for the range.
The significance of effects was determined by comparing Groups B and C with A, and E and F with D
(Wilcoxon Rank Sum Test.)
* P < 0.05. ** P < 0-01. All other values were not significantly different from controls.
TABLE II.-Changes in Immunoglobulin Levels After C. parvum Administration to nu nu
and nu+ Mice
Group Micea
A nu +
B
C
D
E
F
Treatmentb
No treatment
0-7 mg C. parvum i.v.
,,1 0-7 mg C. parvum i.p.
nu nu No treatment
, 0-7 rmg C. parvum i.v.
,,~ 0-7 mg C. parvum i.p.
IgM IgA IgGI IgG2a IgG2b
mg/dlc
38-8 8-8 37-3 66-5 12-2
(30-49) (8-10) (17-45) (48-84) (7-15)
70.7** 6-7* 72-5** 171-0* 23-9**
(54-93) (5-10) (56-149) (60-456) (10-40)
89-1** 8-6 91-7** 252-7** 43-1**
(56-105) (5-10) (66-151) (156-399) (17-64)
55-8
(51-67)
76 -8**
(63-91)
59-4
(41-81)
4-4
(2-7)
6 -4
(3-9)
5-0
(4-8)
52 Id
(0-152)
47-1
(0-776)
73-9
(0-700)
3-8d
(0-167)
79.8*
(13-399)
60-3
(4-664)
17 -0
(10-41)
19-9
(8-42)
25-0
(8-74)
a Each group contained 7 to 8 male mice, the nu nu and nu + being litter-mates.
b 21 days before the serological assays.
c The values expressed are medians with the range in parentheses.
d There was considerable variation in IgGI and IgG2a levels in treated and untreated nude mice. In
certain instances the immunoglobulin levels were so low they were beyond the sensitivity of the Mancini
assay.
The significance of effects was determined by comparing Groups B and C with A, and E and F with D
(Wilcoxon Rank Sum Test).
* P < 0-05. ** P < 0-01. All other values were not significantly different from controls.
groups, but these changes were only
significant in Group C. Offurther interest
was the wide variation in IgGi and IgG2a
levels in all groups of homozygous nude
mice, indicating perhaps infection or
heterogeneity in these mice.
In view of the present observations,
the previously suggested explanations (see
above) ofhow B mice respond toC. parvum
seem less likely. It is more probable that
C. parvum can behave as a partly thymus-
independent antigen. This finding, and
Group Micea
A nu +
B
C
E
F
Spleen weight
mgd
84
(74-93)
206
(112-255)**
302
(116-659)**
76
(65-107)
172
(110-236)**
130
(88-180)**
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the immunoglobulin profile in athymic
mice treated with C. parvum, provide
further confirmation of the inherent
" adjuvanticity" of the organism. The
present experiments also establish that the
increase in certain Ig levels (and possibly
anti-tumourresponses) followingC.parvum
administration are to some extent
independent of T-cell function. These
serological observations are important in
relation to the known antitumour pro-
perties of systemically administered C.
parvum in T-deprived and nude mice
(Woodruff et al., 1973; Woodruff and
Warner, 1977).
We are indebted to the Cancer Re-
search Campaign for generous grant sup-
port and to the Wellcome Foundation for
kindly providing the C. parvum.
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